A detailed history of Virtu Financial LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 14,517 shares of ARVN stock, worth $153,444. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,517
Holding current value
$153,444
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$6.24 - $8.53 $90,586 - $123,830
14,517 New
14,517 $124,000
Q4 2023

Feb 26, 2024

BUY
$14.19 - $42.33 $91,866 - $274,044
6,474 New
6,474 $266,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $562M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.